Skip to main content

Table 2 Bivariate relationship between safer smoking supplies implementation and SSP characteristics in the United States, November–December 2023 (n = 118)

From: Implementation determinants of safer smoking supplies in U.S. syringe services programs

 

Has not implemented smoking supplies (n = 39; 33.1%)

Has implemented smoking supplies (n = 79; 66.9%)

Total (n = 118)a

P-valueb

Unadjusted Prevalence Ratio (95% CI)c

Organizational Characteristics

Region

 Midwestd

7 (17.9%)

12 (15.2%)

19 (16.1%)

0.006*

1.11 (0.93, 1.34)

 Northeaste

3 (7.7%)

18 (22.8%)

21 (17.8%)

 

1.27 (1.09, 1.47)

 Westf

12 (30.8%)

36 (45.6%)

48 (40.7%)

 

1.20 (1.03, 1.38)

 Southg

15 (38.5%)

13 (16.5%)

28 (23.7%)

 

Ref

Urbanicity of areas served$

 Urban&

22 (56.4%)

51 (64.6%)

73 (61.9%)

0.693

–

 Suburban&

10 (25.6%)

27 (34.2%)

37 (31.4%)

0.643

–

 Exurban/Semi-rural&

5 (12.8%)

25 (31.6%)

30 (25.4%)

0.042*

1.14 (1.03, 1.25)

 Rural&

13 (33.3%)

33 (41.8%)

46 (39.0%)

0.676

–

Type of Organization$

 Community-based Organization/Non-profit&

22 (56.4%)

65 (82.3%)

87 (73.7%)

0.011

1.20 (1.06, 1.37)

 City, County, or State Health Department&

15 (38.5%)

16 (20.3%)

31 (26.3%)

0.107

–

 Otherh,&

3 (7.7%)

3 (3.8%)

6 (5.1%)

0.395*

–

Funding sources$

 Federal&

24 (61.5%)

31 (39.2%)

55 (46.6%)

0.074

0.89 (0.80, 0.98)

 State&

32 (82.1%)

66 (83.5%)

98 (83.1%)

0.980

–

 Foundation&

11 (28.2%)

42 (53.2%)

53 (44.9%)

0.037

1.14 (1.04, 1.26)

 Private donations from fundraising&

13 (33.3%)

43 (54.4%)

56 (47.5%)

0.097

1.12 (1.01, 1.24)

 Otheri,&

11 (28.2%)

22 (27.8%)

33 (28.0%)

0.929

–

Duration of operation

 Less than one year

0 (0%)

2 (2.5%)

2 (1.7%)

0.816*

–

 1–2 years

1 (2.6%)

5 (6.3%)

6 (5.1%)

  

 3–5 years

8 (20.5%)

16 (20.3%)

24 (20.3%)

  

 Greater than 5 years

30 (76.9%)

55 (69.6%)

85 (72.0%)

  

Number of unique clients (past month)

 Median [IQR]

165 [288]

300 [551]

300 [499]

0.175

–

 Unsure or missing

16 (41.0%)

20 (25.3%)

36 (30.5%)

  

Services offered$

 Naloxone&

38 (97.4%)

79 (100%)

117 (99.2%)

0.360

–

 Syringes&

32 (82.1%)

77 (97.5%)

109 (92.4%)

0.012

1.40 (1.11, 1.75)

 Safer snorting supplies&

4 (10.3%)

60 (75.9%)

64 (54.2%)

 < 0.001*

1.43 (1.30, 1.58)

 Anal administration supplies&

10 (25.6%)

52 (65.8%)

62 (52.5%)

 < 0.001

1.24 (1.12, 1.37)

 Basic first aid&

35 (89.7%)

74 (93.7%)

109 (92.4%)

0.751

–

 Food&

18 (46.2%)

52 (65.8%)

70 (59.3%)

0.123

–

 Safer sex supplies&

37 (94.9%)

77 (97.5%)

114 (96.6%)

0.764

–

 HIV testing&

28 (71.8%)

56 (70.9%)

84 (71.2%)

0.995

–

 Hepatitis C testing&

26 (66.7%)

51 (64.6%)

77 (65.3%)

0.975

–

 PrEP or PEP for HIV&

14 (35.9%)

27 (34.2%)

41 (34.7%)

0.983

–

 HIV treatment&

7 (17.9%)

17 (21.5%)

24 (20.3%)

0.902

–

 Hepatitis C treatment&

8 (20.5%1.)

19 (24.1%)

27 (22.9%)

0.912

–

 STI testing&

17 (43.6%)

41 (51.9%)

58 (49.2%)

0.697

–

 STI treatment&

15 (38.5%)

23 (29.1%)

38 (32.2%)

0.593

–

 Basic clinical services&

15 (38.5%)

27 (34.2%)

42 (35.6%)

0.901

–

 Mental health services&

15 (38.5%)

20 (25.3%)

35 (29.7%)

0.339

–

 Referrals&

35 (89.7%)

71 (89.9%)

106 (89.8%)

1.000

–

 Case management/housing coordination services&

18 (46.2%)

41 (51.9%)

59 (50.0%)

0.842

–

 MOUD coordination&

23 (59.0%)

44 (55.7%)

67 (56.8%)

0.944

–

Duration of providing syringesj

   

0.951*

–

 Less than one year

2 (5.1%)

3 (3.8%)

5 (4.2%)

  

 1–2 years

3 (7.7%)

8 (10.1%)

11 (9.3%)

  

 3–5 years

9 (23.1%)

18 (22.8%)

27 (22.9%)

  

 Greater than 5 years

18 (46.2%)

44 (55.7%)

62 (52.5%)

  

 Unsure or missing

7 (17.9%)

6 (7.6%)

13 (11.0%)

  

Implementation Determinants

Perceived change in demand for smoking supplies (past 6 months)

   

 < 0.001*

 

 Increased

19 (48.7%)

59 (74.7%)

78 (66.1%)

 

1.06 (0.93, 1.21)

 Decreased

0 (0.00%)

0 (0.00%)

0 (0.00%)

 

N/A

 Unsure

12 (30.8%)

1 (1.3%)

13 (11.0%)

 

0.65 (0.55, 0.78)

 Remained the same

8 (20.5%)

15 (19.0%)

23 (19.5%)

 

Ref

Barriers to implementation$

Outer context

 Local policies&

21 (53.8%)

27 (34.2%)

48 (40.7%)

0.123

–

 Federal policies&

13 (33.3%)

24 (30.4%)

37 (31.4%)

0.948

–

 External opposition&

15 (38.5%)

14 (17.7%)

29 (24.6%)

0.048

0.86 (0.75, 0.98)

 Fear of external pushback&

17 (43.6%)

18 (22.8%)

35 (29.7%)

0.067

0.87 (0.77, 0.99)

 Insufficient funding&

22 (56.4%)

46 (58.2%)

68 (57.6%)

0.982

–

Inner context

 Unsure of the evidence&

6 (15.4%)

2 (2.5%)

8 (6.8%)

0.155*

–

 Internal leadership opposition&

11 (28.2%)

6 (7.6%)

17 (14.4%)

0.011

0.79 (0.66, 0.94)

 Limited awareness of need from staff/leadership&

8 (20.5%)

9 (11.4%)

17 (14.4%)

0.415

–

 Limited interest from SSP clients&

1 (2.6%)

0 (0%)

1 (0.8%)

0.331*

–

 Unsure of best practices for implementation&

4 (10.3%)

5 (6.3%)

9 (7.6%)

0.476*

–

 Missing

0 (0.0%)

5 (6.3%)

5 (4.2%)

0.169*

–

  1. a Percentage (%) values may not add up to 100% due to rounding
  2. b P-values are from chi-square and Fisher’s exact tests (for variables with cell counts ≤ 5) for categorical variables and Students t-tests for continuous variables
  3. c Prevalence ratios and 95% confidence intervals were estimated using modified Poisson regression with ‘has not implemented safer smoking supplies’ as the reference group
  4. d Includes: Illinois, Indiana, Iowa, Kansas, Michigan, Minnesota, Missouri, Nebraska, North Dakota, Ohio, South Dakota, Wisconsin
  5. e Includes: Connecticut, Maine, Massachusetts, New Hampshire, New Jersey, New York, Pennsylvania, Rhode Island, Vermont
  6. f Includes: Alaska, Arizona, California, Colorado, Hawaii, Idaho, Montana, Nevada, New Mexico, Oregon, Utah, Washington, Wyoming
  7. g Includes: Alabama, Arkansas, Delaware, Washington D.C., Florida, Georgia, Kentucky, Louisiana, Maryland, Mississippi, North Carolina, Oklahoma, South Carolina, Tennessee, Texas, Virginia, West Virginia, Puerto Rico
  8. h Defined as tribal affiliated organization, academic healthcare organization, or private or commercial health organization
  9. i Defined as university funding or other
  10. j This question was only asked of organizations that provide syringes (n = 109)
  11. * P-value is for Fisher’s exact test due to low cell count (≤ 5 observations)
  12. $ Variable was ‘select all that apply’ and therefore cell counts add up to greater than the total number of observations
  13. & ‘Select all that apply’ exposures (e.g., urbanicity) were analyzed as separate binary indicator variables (i.e., presence vs. absence of that category). Because respondents could select multiple categories, each p-value reflects a comparison between those who selected the given category and those who did not (e.g., urban vs. non-urban)
  14. SSP Syringe services program, IQR Interquartile range, HIV Human immunodeficiency virus, PrEP = HIV pre-exposure prophylaxis, PEP HIV post-exposure prophylaxis, STI Sexually transmitted infection, MOUD  Medications for opioid use disorder